• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.

作者信息

Loskutoff D J, Roegner K, Erickson L A, Schleef R R, Huttenlocher A, Coleman P L, Gelehrter T D

出版信息

Thromb Haemost. 1986 Feb 28;55(1):8-11.

PMID:3486492
Abstract

Glucocorticoids decrease plasminogen activator (PA) activity in HTC rat hepatoma cells by inducing a specific inhibitor of PA activity (PAI). This inhibitor is similar in several biochemical properties to the PAI purified from bovine aortic endothelial cells (BAEs). We have used reverse fibrin autography and antiserum against BAE PAI to establish more fully the biochemical and immunological relationship of these inhibitors. Both inhibitors migrated with an apparent Mr of approximately 50,000, and the activity of both PAIs was stimulated by treatment with SDS suggesting that each of these molecules exists in both an active and a latent form. Antiserum to the BAE PAI immunoprecipitated all of the HTC PAI demonstrable by reverse fibrin autography. Finally, using this antiserum in a functional immunoassay, we have demonstrated that dexamethasone increases both active and latent PAI made by HTC cells. These results indicate that HTC PAI and BAE PAI are antigenically as well as biochemically related molecules.

摘要

相似文献

1
The dexamethasone-induced inhibitor of plasminogen activator in hepatoma cells is antigenically-related to an inhibitor produced by bovine aortic endothelial cells.
Thromb Haemost. 1986 Feb 28;55(1):8-11.
2
Immunoaffinity purification of HTC rat hepatoma cell plasminogen activator-inhibitor-1.HTC大鼠肝癌细胞纤溶酶原激活物抑制剂-1的免疫亲和纯化
Thromb Haemost. 1987 Dec 18;58(4):1017-23.
3
Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.在人体细胞中检测1型和2型纤溶酶原激活物抑制剂
J Cell Physiol. 1988 Feb;134(2):269-74. doi: 10.1002/jcp.1041340213.
4
Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
Mol Endocrinol. 1987 Jan;1(1):97-101. doi: 10.1210/mend-1-1-97.
5
Transcriptional and posttranscriptional regulation of type 1 plasminogen activator inhibitor and tissue-type plasminogen activator gene expression in HTC rat hepatoma cells by glucocorticoids and cyclic nucleotides.糖皮质激素和环核苷酸对HTC大鼠肝癌细胞中1型纤溶酶原激活物抑制剂和组织型纤溶酶原激活物基因表达的转录和转录后调控
Mol Endocrinol. 1992 Jan;6(1):53-60. doi: 10.1210/mend.6.1.1738371.
6
Influence of nicotine and cotinine on the expression of plasminogen activator activity in bovine aortic endothelial cells.尼古丁和可替宁对牛主动脉内皮细胞中纤溶酶原激活物活性表达的影响。
Thromb Haemost. 1989 Feb 28;61(1):70-6.
7
Glucocorticoid induction of plasminogen activator and plasminogen activator-inhibitor messenger RNA in rat hepatoma cells.
Mol Endocrinol. 1989 Feb;3(2):349-55. doi: 10.1210/mend-3-2-349.
8
Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.内皮细胞产生一种纤溶酶原激活物的潜在抑制剂,该抑制剂可被变性剂激活。
J Biol Chem. 1985 Sep 25;260(21):11581-7.
9
Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.血管生成抑制性类固醇的作用机制:通过刺激纤溶酶原激活物抑制剂的合成来抑制纤溶酶原激活物活性。
J Cell Physiol. 1993 Jun;155(3):568-78. doi: 10.1002/jcp.1041550315.
10
Plasminogen activator inhibitor type 1 production by rat type II pneumocytes in culture.培养的大鼠II型肺细胞产生1型纤溶酶原激活物抑制剂
Am J Respir Cell Mol Biol. 1992 Feb;6(2):133-9. doi: 10.1165/ajrcmb/6.2.133.

引用本文的文献

1
Hemostatic changes in patients with brain tumors.脑肿瘤患者的止血变化。
J Neurooncol. 1994;22(2):87-100. doi: 10.1007/BF01052885.
2
Association of a plasminogen activator inhibitor (PAI-1) with the growth substratum and membrane of human endothelial cells.纤溶酶原激活物抑制剂-1(PAI-1)与人内皮细胞生长基质及细胞膜的关联。
J Cell Biol. 1987 Dec;105(6 Pt 1):2543-9. doi: 10.1083/jcb.105.6.2543.
3
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.
转化生长因子-β是WI-38人肺成纤维细胞中1型纤溶酶原激活物抑制剂mRNA水平的一种强效且作用迅速的正向调节因子。
EMBO J. 1987 May;6(5):1281-6. doi: 10.1002/j.1460-2075.1987.tb02365.x.
4
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.编码人β-迁移内皮细胞型纤溶酶原激活物抑制剂的cDNA的克隆与序列分析
Proc Natl Acad Sci U S A. 1986 Sep;83(18):6776-80. doi: 10.1073/pnas.83.18.6776.
5
Type 1 plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter.1型纤溶酶原激活物抑制剂基因:其启动子的功能分析及糖皮质激素调控
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5525-9. doi: 10.1073/pnas.85.15.5525.
6
Plasminogen activator inhibitor (type-1) in rat adrenal medulla.大鼠肾上腺髓质中的纤溶酶原激活物抑制剂(1型)
Histochemistry. 1989;92(5):377-83. doi: 10.1007/BF00492494.
7
The c-myc-regulated gene mrl encodes plasminogen activator inhibitor 1.c-myc调控基因mrl编码纤溶酶原激活物抑制剂1。
Mol Cell Biol. 1990 Mar;10(3):1265-9. doi: 10.1128/mcb.10.3.1265-1269.1990.
8
Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.表皮生长因子对Hep G2细胞中纤溶酶原激活物抑制剂1型mRNA的转录调控
Nucleic Acids Res. 1991 Jan 11;19(1):163-8. doi: 10.1093/nar/19.1.163.